Editor's Comparative Analysis

When choosing between Pharmaciana and Al-Mustansiriyah Journal of Pharmaceutical Sciences, researchers should consider the trade-off between prestige (Al-Mustansiriyah Journal of Pharmaceutical Sciences leads with an IF of 56.90) and publication speed.

Pharmaciana is published in ID, while Al-Mustansiriyah Journal of Pharmaceutical Sciences is headquartered in IQ. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.

Academic Metric Pharmaciana Al-Mustansiriyah Journal of Pharmaceutical Sciences
General Information
Publisher Universitas Ahmad Dahlan College of Pharmacy / Mustansiriyah University
Country of Origin ID IQ
Established 2021 2024
Editor-in-Chief See Website See Website
Scientific Influence
Current Impact Factor N/A
56.90
Indexing Status
DOAJ
DOAJ
Review Speed (Decision) Unknown 102 days
Standard
Acceptance Rate N/A N/A
Access & Publication Fees
Open Access Type Full OA Full OA
APC Fee (Estimated) $1,200,000.00 $95.00
Historical Impact Factor Comparison
About Pharmaciana

Pharmaciana is a prominent academic journal specializing in Pharmacy and materia medica. Published by Universitas Ahmad Dahlan in ID, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2088-4559. The journal aims to advance the boundaries …

View Full Profile
About Al-Mustansiriyah Journal of Pharmaceutical Sciences

Al-Mustansiriyah Journal of Pharmaceutical Sciences is a prominent academic journal specializing in Pharmacy and materia medica. Published by College of Pharmacy / Mustansiriyah University in IQ, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 1815-0993. …

View Full Profile

Searching for: Pharmaciana impact factor, Al-Mustansiriyah Journal of Pharmaceutical Sciences APC fees, journal comparison tool 2026.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now